Tradestie Institutional Equity Comparison Engine

LYRA vs AVTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVTX Overall Edge

AVTX Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avalo Therapeutics, Inc. Common Stock (AVTX) driven by superior Growth & Margin, Momentum & Technical while LYRA counters with relative strength in Options & Structure. Fundamentally, LYRA trades at N/M Forward P/E with -25032.0% operating margin (-87.2% YoY revenue) versus AVTX at N/M Forward P/E and -161962.7% operating margin (-69.3% YoY). In options structure, LYRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AVTX sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
LYRA N/M vs AVTX N/M Fwd P/E
Growth & Margin Winner AVTX
Op Margin -25032.0% vs -161962.7% ยท YoY -87.2% vs -69.3%
Momentum & Technical Winner AVTX
1Y -94.3% vs -53.4% ยท 52W Pos 1% vs 3%
Options & Structure Winner LYRA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (22nd %ile IV)
LYRA NASDAQ
Lyra Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.49
-62.5% 1D
Market Cap $2.3M
1M Return -62.5%
1Y Return -94.34%
Forward P/E N/M
Unified AI Score
52.2 / 100 HOLD
Tech 60.0 Fund 56.0 Flow 50.0 Mom 59.0
AVTX NASDAQ
Avalo Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$7.04
-4.48% 1D
Market Cap $448.7M
1M Return -39.26%
1Y Return -53.41%
Forward P/E N/M
Unified AI Score
49.6 / 100 HOLD
Tech 69.0 Fund 65.0 Flow 64.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LYRA -94.34% AVTX -53.41% Spread: +93.16 pp (AVTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period LYRA Revenue AVTX Revenue LYRA Op. Margin AVTX Op. Margin Margin Edge
FY2018 N/A $10M N/A -503.4% AVTX
FY2019 N/A $10M N/A -239.1% AVTX
FY2020 N/A $10M N/A -1087.4% AVTX
FY2021 $0M $10M -15303.5% -1521.6% AVTX
FY2022 $0M $20M -4131.0% -207.4% AVTX
FY2023 $0M $0M -4308.1% -1421.6% AVTX
FY2024 $0M $0M -6280.8% -15535.6% LYRA
FY2025 $0M $0M -7794.5% -123601.7% LYRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LYRA (2) vs AVTX (5)
Institutional Metric LYRA AVTX Criterion Row Winner
Market Capitalization Scale $2.3M $448.7M Larger Scale AVTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -87.2% -69.3% Higher Growth AVTX
Operating Margin (TTM) Profitability -25032.0% -161962.7% Higher Margin LYRA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -404.5% -33.6% Higher ROE AVTX
52-Week Range Position Momentum 1% ($0โ€“$38) 3% ($7โ€“$24) Stronger Trend AVTX
Beta / 30D Volatility Risk Regime 0.33ฮฒ ยท 248% Vol 1.74ฮฒ ยท 164% Vol Lower Realized Risk AVTX
Unified Institutional Score Composite Signal 52.2 / 100 (HOLD) 49.6 / 100 (HOLD) Higher Composite LYRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LYRA vs AVTX Buy Guide
LYRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LYRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVTX BREAKDOWN
134d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AVTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LYRA nor AVTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.